申请人:Knolle Jochen
公开号:US20080194524A1
公开(公告)日:2008-08-14
The present invention is related to compounds having formula (I)
wherein the dashed line indicates a single or double bond or is absent and wherein A
1
-A
9
, Q, R
1
-R
11
, T, U, V, W
1
-W
3
, X
1
, X
2
, Y and Z are as defined in the claims and description, pharmaceutical compositions comprising the compounds and the use of the compounds for the manufacture of a medicament for the treatment of diseases involving abnormal cell proliferation, undesired cell proliferation, abnormal mitosis and/or undesired mitosis.
本发明涉及具有式(I)的化合物,其中虚线表示单键或双键或不存在,A1-A9,Q,R1-R11,T,U,V,W1-W3,X1,X2,Y和Z如权利要求和说明书所定义,包括该化合物的制药组合物和用于制造治疗涉及异常细胞增殖、不良细胞增殖、异常有丝分裂和/或不良有丝分裂疾病药物的化合物的用途。